Hospitality venture planned for historic York building
UK economy contracts after better than expected first quarter
CMA probes Evri–DHL ecommerce merger
The UK’s Competition and Markets Authority (CMA) is reviewing the proposed merger between parcel delivery firm Evri and DHL Group’s UK ecommerce logistics division. The deal, announced in May, would see DHL Group take a significant minority stake in Evri, while Apollo-managed funds retain majority control.
The combined operation would bring together more than 30,000 couriers and van drivers, 12,000 employees, and a fleet of 8,000 vehicles. Together, they are expected to handle over one billion parcels and one billion business letters annually.
The CMA is assessing whether the transaction could substantially lessen competition in the UK parcel delivery and ecommerce logistics market. As part of its standard process, the regulator has invited to comment from interested parties, which closes on 25 June.
Evri, formerly Hermes UK, traces its origins to Grattan Mail Order in Bradford in 1974. It currently operates over 10,000 out-of-home locations and has a growing network of automated hubs and depots nationwide. The merger is positioned by both parties as a move to enhance consumer and business delivery options through improved scale and efficiency.
British Business Bank expands financial reach to support growth
The British Business Bank’s financial capacity is being raised to £25.6 billion, allowing it to scale up investments to approximately £2.5 billion annually. The expansion aims to unlock significant private capital and support high-growth, innovation-driven UK firms, particularly those in the life sciences, deep tech, and venture capital sectors.
The move follows confirmation of governance and financial reforms to the Bank, as outlined in the latest government Spending Review. These changes are expected to be implemented by the end of the current financial year.
The Bank has already backed 22 of the UK’s current unicorns through its equity programmes, representing over half of all such firms in the country. With its expanded mandate, the institution is expected to play a pivotal role in delivering the government’s upcoming Industrial Strategy and broader ambitions for regional growth and scale-up funding.
Business confidence rebounds but hiring and demand remain uneven
New data from NatWest’s May Regional Growth Tracker points to a modest resurgence in business confidence across the UK, with firms reporting more optimistic outlooks and slight improvements in activity levels. Half of the 12 monitored regions reported growth in output, while sentiment about future activity rose in all areas. The North West and London saw the largest monthly increases in expectations, with the West Midlands remaining the most optimistic overall.
However, the recovery remains patchy. Wales posted the fastest growth in business activity during May, while London recorded its weakest performance in two and a half years. Inflows of new business rose only in Wales and stabilised in the East of England, with all other regions seeing a drop, led by a sharper decline in the East Midlands.
Employment figures were generally down, with Scotland being the only region to report a slight increase in headcount after six months of stagnation. The North West continued to cut jobs for the eighth straight month, though the pace slowed.
Order backlogs fell across the board for the third consecutive month, with the North West experiencing the most significant drop in outstanding work. Scotland saw the mildest decline.
Pricing trends moderated slightly, with the rate of increase in average prices charged slowing in every region compared to April. Wales recorded the biggest fall in output price inflation, while Northern Ireland and the West Midlands saw the highest ongoing pressure.
Input costs rose at a softer pace than the previous month but remained above historical norms. The South West and East of England faced the steepest increases, while Scotland saw the most subdued rise. Businesses continue to raise prices to manage persistent cost pressures, including rising labour expenses following April’s national insurance changes.
Construction ball raises £30,000 for St Luke’s Hospice
Royal recognition opportunity for high-performing businesses
North Lincolnshire businesses have the opportunity to gain national prestige through the King’s Awards for Enterprise, with applications now open until 9 September 2025.
Open to companies, non-profits, and public sector bodies with at least two UK-based employees, the awards celebrate excellence across four categories: innovation, international trade, sustainable development, and promoting opportunity through social mobility.
Winners benefit from national visibility, use of the King’s Awards emblem, and access to high-level networking via a Royal reception. Honourees also receive an official visit from the Lord-Lieutenant, acting on behalf of His Majesty The King.
The awards are designed to recognise organisations with strong environmental, social, and governance (ESG) credentials, making them especially relevant to B2B firms looking to enhance credibility, attract partnerships, and scale operations in competitive markets.
North Lincolnshire Council has encouraged local businesses across key industries, including engineering, manufacturing, and logistics, to leverage this platform for growth and recognition. Recent winners such as Wrendale Designs have reported tangible benefits in staff morale, global brand perception, and new market access following their award.
The application process is now live. Interested businesses are advised to begin preparations early to meet the September deadline.
Rabobank backs third UK solar project with Aura Power
Aura Power has secured financing from Rabobank for its third UK solar installation, the 49.9MW Grimsby Solar Farm in North East Lincolnshire. The funding adds to two previous deals between the developer and the Dutch bank: £44 million for the Kemble Solar Farm in Gloucestershire and £33.1 million for Burtree Lane in County Durham.
All three projects fall under the UK’s Contracts for Difference Allocation Round 5. Preliminary work on the Grimsby substation is already underway, with complete construction due to start shortly and energisation targeted for early 2026.
This move strengthens Aura Power’s UK pipeline, which totals 0.5GWp and is expected to be built out by 2028. The Bristol-based firm also has a global solar and battery energy storage pipeline of approximately 12GW.
Rabobank has been accelerating its UK clean energy portfolio. In recent months, it committed £135 million to Aukera Energy for five solar projects totalling 220MWp and co-financed a £42 million loan with ING for 125MW of battery storage projects led by Field. It also supported Enray Power in closing finance for the 68.5MWp Camblesforth Solar Farm, which includes a co-located 24MWh battery.
Qualcomm to acquire Leeds’ Alphawave Semi
University of Sheffield spinout company awarded £2.3m to develop motor neuron disease therapies
Biotechnology company Crucible Therapeutics, a University of Sheffield spinout company, has been awarded £2.3m to develop breakthrough therapies that address underlying causes of motor neuron disease (MND).
The grant from the Innovate UK Biomedical Catalyst program will support the advancement of Crucible’s differentiated siRNA program aimed at treating MND, which is also known as amyotrophic lateral sclerosis (ALS), and other devastating neurodegenerative conditions.
The funding will enable Crucible, in partnership with Sheffield Institute of Translational Neuroscience (SITraN), to scale up manufacturing and advance its lead clinical candidate into pivotal non-clinical safety studies – an essential step toward initiating first-in-human clinical trials for MND/ALS.
Crucible’s unique therapeutic approach targets rogue RNA molecules and toxic proteins that contribute to neurodegeneration, aiming to protect motor neurons from progressive damage. This innovative strategy holds promise as a first-in-class, disease-modifying treatment for patients affected by MND/ALS.
MND/ALS is a progressive, fatal neurodegenerative disorder characterised by muscle weakness, paralysis, and ultimately respiratory failure. Toxic protein accumulation, seen in the vast majority of MND cases, directly damages motor neurons, disrupting nerve signaling and leading to severe muscle atrophy and loss of function that defines the disease.
Jonathan Foley, executive director and CDO of Crucible Therapeutics, said: “We are thrilled to receive Innovate UK funding as part of the Biomedical Catalyst, which will accelerate our research into a potential new treatment for ALS. This funding will support crucial translational research that brings us a step closer to delivering a therapy that could make a real difference for people living with this devastating disease.”